Metastatic Breast Cancer
Conference Coverage
This breast tumor subtype disproportionately affects Black women
HR-positive basal tumors are overrepresented in Black women and may be biologically similar to TNBC.
Conference Coverage
Metastatic lobular, ductal cancers respond similarly
Lobular cancers differ physiologically, but trial results generally apply to ductal tumors.
Conference Coverage
Survival for elderly breast cancer patients 25% after 4 years
The finding is based on an analysis of data between 2012 and 2016 from the SEER-Medicare database.
Conference Coverage
‘Large benefit’ in ovarian function suppression for breast cancer
Absolute gain for adding ovarian function suppression to tamoxifen increases with longer follow-up.
Conference Coverage
Neighborhood analysis links breast cancer outcomes to socioeconomic status
“This study should make clinicians cognizant of the potential for biases in management of metastatic breast cancer in terms of socioeconomic...
Conference Coverage
Autoimmune disease linked to better late-stage breast cancer survival
Retrospective data hint at antitumor activity, but other explanations are possible
Conference Coverage
Breast cancer deaths take a big dip because of new medicines
Research model suggests a 58% overall mortality decline in 2019 from metastatic breast cancer.
Conference Coverage
Pseudocirrhosis in breast cancer may signal liver metastases
A better understanding of this common comorbidity could lead to better management and treatment.
Conference Coverage
Excess weight may ward off infection in breast cancer treatment
The study demonstrated significantly less frequent and less severe neutropenia in overweight and obese patients.
Conference Coverage
Women with HER2+ metastatic breast cancer are living longer
Overall survival improved 5.6% each year among over 5,000 patients in the study.
Conference Coverage
Treating bone loss ups survival for breast cancer patients
Findings suggest a trend toward reduction in contralateral breast cancer in the treatment group.